Evolution of antimicrobial peptides to self-assembled peptides for biomaterial applications

Pathogens

Volumn 3, Issue 4, 2014, Pages 792-821

  McCloskey, Alice P ^a   Gilmore, Brendan F ^a   Laverty, Garry ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Antimicrobial; Bacteria; Biofilm; Biomaterial; Infection; Peptide; Self assembly

Indexed keywords

BIOMATERIAL; CECROPIN A; CHLORHEXIDINE; COLISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; FENTANYL; MAGAININ 2; MINOCYCLINE; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; SELF ASSEMBLING BIOMATERIAL; SULFADIAZINE; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; BACTERIAL VIABILITY; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOFILM; CATHETER INFECTION; COST EFFECTIVENESS ANALYSIS; ENZYME SPECIFICITY; GELATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIC STRENGTH; MEDICAL DEVICE COMPLICATION; MICROBIAL ADHESION; NONHUMAN; PH; REVIEW; TISSUE ENGINEERING;

EID: 85000501966     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens3040791     Document Type: Review

References (157)

1. Bryers, J.D. Medical biofilms. Biotechnol. Bioeng. 2008, 100, 1-18.
2. Ratner, B.D.; Hoffman, A.S.; Schoen, F.J.; Lemons, J.E. Introduction-Biomaterials Science: An Evolving, Multidisciplinary Endeavor. In Biomaterials Science; Ratner, B.D., Hoffman, A.S., Schoen, F.J., Lemons, J.E., Eds.; Academic Press Elsevier Inc.: Waltham, MA, USA, 2013; pp. 1-20.
3. Kojic, E.M.; Darouiche, R.O. Candida infections of medical devices. Clin. Microbiol. Rev. 2004, 17, 255-267.
4. Grainger, D.W.; van der Mei, H.C.; Jutte, P.C.; van den Dungen, J.J.; Schultz, M.J.; van der Laan, B.F.; Zaat, S.A.; Busscher, H.J. Critical factors in the translation of improved antimicrobial strategies for medical implants and devices. Biomaterials 2013, 34, 9237-9243.
5. Zaveri, T.D.; Lewis, J.S.; Dolgova, N.V.; Clare-Salzler, M.J.; Keselowsky, B.G. Integrin-directed modulation of macrophage responses to biomaterials. Biomaterials 2014, 35, 3504-3515.
6. Anderson, J.M. Biological Responses to Materials. Annu. Rev. Mater. Res. 2001, 31, 81-110.
7. Darouiche, R.O. Treatment of infections associated with surgical implants. N. Engl. J. Med. 2004, 350, 1422-1429.
8. Kaplan, J.B. Antibiotic-induced biofilm formation. Int. J. Artif. Organs 2011, 34, 737-751.
9. Busscher, H.J.; van der Mei, H.C.; Subbiahdoss, G.; Jutte, P.C.; van den Dungen, J.J.; Zaat, S.A.; Schultz, M.J.; Grainger, D.W. Biomaterial-associated infection: Locating the finish line in the race for the surface. Sci. Transl. Med. 2012, 4, 153rv10.
10. O’Toole, G.; Kaplan, H.B.; Kolter, R. Biofilm formation as microbial development. Annu. Rev. Microbiol. 2000, 54, 49-79.
11. Gilbert, P.; Maira-Litran, T.; McBain, A.J.; Rickard, A.H.; Whyte, F.W. The physiology and collective recalcitrance of microbial biofilm communities. Adv. Microb. Physiol. 2002, 46, 202-256.
12. Francolini, I.; Donelli, G. Prevention and control of biofilm-based medical-device-related infections. FEMS Immunol. Med. Microbiol. 2010, 59, 227-238.
13. Koenig, A.L.; Gambillara, V.; Grainger, D.W. Correlating fibronectin adsorption with endothelial cell adhesion and signaling on polymer substrates. J. Biomed. Mater. Res. A 2003, 64, 20-37.
14. MacKintosh, E.E.; Patel, J.D.; Marchant, R.E.; Anderson, J.M. Effects of biomaterial surface chemistry on the adhesion and biofilm formation of Staphylococcus epidermidis in vitro. J. Biomed. Mater. Res. A 2006, 78, 836-842.
15. Gottenbos, B.; van der Mei, H.C.; Busscher, H.J. Initial adhesion and surface growth of Staphylococcus epidermidis and Pseudomonas aeruginosa on biomedical polymers. J. Biomed. Mater. Res. 2000, 50, 208-214.
16. Hu, J.; Xu, T.; Zhu, T.; Lou, Q.; Wang, X.; Wu, Y.; Huang, R.; Liu, J.; Liu, H.; Yu, F. et al. Monoclonal antibodies against accumulation-associated protein affect EPS biosynthesis and enhance bacterial accumulation of Staphylococcus epidermidis. PLoS One 2011, 6, e20918.
17. Costerton, J.W.; Montanaro, L.; Arciola, C.R. Bacterial communications in implant infections: A target for an intelligence war. Int. J. Artif. Organs 2007, 30, 757-763.
18. Fux, C.A.; Costerton, J.W.; Stewart, P.S.; Stoodley, P. Survival strategies of infectious biofilms. Trends Microbiol. 2005, 13, 34-40.
19. Donlan, R.M. Biofilm formation: A clinically relevant microbiological process. Clin. Infect. Dis. 2001, 33, 1387-1392.
20. Nordmann, P.; Poirel, L.; Toleman, M.A.; Walsh, T.R. Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J. Antimicrob. Chemother. 2011, 66, 689-692.
21. Brooks, B.D.; Brooks, A.E.; Grainger, D.W. Immunological Aspects and Antimicrobial Strategies, Antimicrobial Medical Devices in Preclinical Development and Clinical Use. In Biomaterials associated infection; Moriaty, F.T., Zaat, S.A., Busscher, H.J., Eds.; Springer: New York, NY, USA, 2013; pp. 307-354.
22. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance; WHO Press: Geneva, Switzerland, 2014.
23. Crnich, C.J.; Drinka, P. Medical device-associated infections in the long-term care setting. Infect. Dis. Clin. N. Am. 2012, 26, 143-164.
24. Donlan, R.M. Biofilms and device-associated infections. Emerg. Infect. Dis. 2001, 7, 277-281.
25. Plowman, R. The socioeconomic burden of hospital acquired infection. Eur. Surveill. 2000, 5, 4.
26. Pittet, D.; Allegranzi, B.; Boyce, J.; World Health Organization World Alliance for Patient Safety First Global Patient Safety Challenge Core Group of Experts The World Health Organization Guidelines on Hand Hygiene in Health Care and their consensus recommendations. Infect. Control Hosp. Epidemiol. 2009, 30, 611-622.
27. Langer, R.; Tirrell, D.A. Designing materials for biology and medicine. Nature 2004, 428, 487-492.
28. Saldarriaga Fernandez, I.C.; van der Mei, H.C.; Lochhead, M.J.; Grainger, D.W.; Busscher, H.J. The inhibition of the adhesion of clinically isolated bacterial strains on multi-component cross-linked poly(ethylene glycol)-based polymer coatings. Biomaterials 2007, 28, 4105-4112.
29. Zhang, Z.; Nix, C.A.; Ercan, U.K.; Gerstenhaber, J.A.; Joshi, S.G.; Zhong, Y. Calcium binding-mediated sustained release of minocycline from hydrophilic multilayer coatings targeting infection and inflammation. PLoS One 2014, 9, e84360.
30. Adams, D.J. Dipeptide and tripeptide conjugates as low-molecular-weight hydrogelators. Macromol. Biosci. 2011, 11, 160-173.
31. Kopecek, J.; Yang, J. Peptide-directed self-assembly of hydrogels. Acta Biomater. 2009, 5, 805-816
32. Peppas, N.A.; Bures, P.; Leobandung, W.; Ichikawa, H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 2000, 50, 27-46.
33. Ahearn, D.G.; Grace, D.T.; Jennings, M.J.; Borazjani, R.N.; Boles, K.J.; Rose, L.J.; Simmons, R.B.; Ahanotu, E.N. Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections. Curr. Microbiol. 2000, 41, 120-125.
34. Wang, Y.; Burgress, D.J.; Aagaard, J. Drug Device Combination Products. In Drug Device Combination Products: Delivery Technologies and Applications; Lewis, A., Ed.; Woodhead Publishing Ltd.: Cambridge, UK, 2010; pp. 11-12.
35. Gaonkar, T.A.; Modak, S.M. Comparison of microbial adherence to antiseptic and antibiotic central venous catheters using a novel agar subcutaneous infection model. J. Antimicrob. Chemother. 2003, 52, 389-396.
36. Yorganci, K.; Krepel, C.; Weigelt, J.A.; Edmiston, C.E. In vitro evaluation of the antibacterial activity of three different central venous catheters against Gram-positive bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 2002, 21, 379-384.
37. Gransden, W.R. Antibiotic resistance. Nosocomial Gram-negative infection. J. Med. Microbiol. 1997, 46, 436-439.
38. Thomas, W.E.; Trintchina, E.; Forero, M.; Vogel, V.; Sokurenko, E.V. Bacterial adhesion to target cells enhanced by shear force. Cell 2002, 109, 913-923.
39. Rachid, S.; Ohlsen, K.; Witte, W.; Hacker, J.; Ziebuhr, W. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob. Agents Chemother. 2000, 44, 3357-3363.
40. Laverty, G.; Gorman, S.P.; Gilmore, B.F. Biomolecular mechanisms of staphylococcal biofilm formation. Future Microbiol. 2013, 8, 509-524.
41. Danese, P.N. Antibiofilm approaches: Prevention of catheter colonization. Chem. Biol. 2002, 9, 873-880.
42. Rochford, E.T.J.; Jaekel, D.J.; Hickok, N.J.; Richards, R.G.; Moriarity, T.F.; Poulsson, A.H.C. PEEK Biomaterials Handbook; Kurtz, S.M., Ed.; Elsevier: Oxford, UK, 2012; pp. 104-105.
43. Veiga, A.S.; Schneider, J.P. Antimicrobial hydrogels for the treatment of infection. Biopolymers 2013, 100, 637-644.
44. Laverty, G.; Gorman, S.P.; Gilmore, B.F. The potential of antimicrobial peptides as biocides. Int. J. Mol. Sci. 2011, 12, 6566-6596.
45. Laverty, G.; McLaughlin, M.; Shaw, C.; Gorman, S.P.; Gilmore, B.F. Antimicrobial activity of short, synthetic cationic lipopeptides. Chem. Biol. Drug Des. 2010, 75, 563-569.
46. Laverty, G.; Gorman, S.P.; Gilmore, B.F. Antimicrobial peptide incorporated poly(2-hydroxyethyl methacrylate) hydrogels for the prevention of Staphylococcus epidermidis-associated biomaterial infections. J. Biomed. Mater. Res. A 2012, 100, 1803-1814.
47. Bahar, A.A.; Ren, D. Antimicrobial peptides. Pharmaceuticals [Basel] 2013, 6, 1543-1575.
48. Dasgupta, A.; Mondal, J.H.; Das, D. Peptide hydrogels. RSC Adv. 2013, 3, 9117-9149.
49. Yang, Z.; Liang, G.; Guo, Z.; Guo, Z.; Xu, B. Intracellular hydrogelation of small molecules inhibits bacterial growth. Angew. Chem. Int. Ed. Engl. 2007, 46, 8216-8219.
50. Liu, Y.; Yang, Y.; Wang, C.; Zhao, X. Stimuli-responsive self-assembling peptides made from antibacterial peptides. Nanoscale 2013, 5, 6413-6421.
51. Kushner, D.J. Self-assembly of biological structures. Bacteriol. Rev. 1969, 33, 302-345.
52. Zhang, S. Fabrication of novel biomaterials through molecular self-assembly. Nat. Biotechnol. 2003, 21, 1171-1178.
53. Stephanopoulos, N.; Ortony, J.H.; Stupp, S.I. Self-Assembly for the Synthesis of Functional Biomaterials. Acta Mater 2013, 61 912-930.
54. Whitesides, G.M.; Grzybowski, B. Self-assembly at all scales. Science 2002, 295, 2418-2421.
55. Javid, N.; Roy, S.; Zelzer, M.; Yang, Z.; Sefcik, J.; Ulijn, R.V. Cooperative self-assembly of peptide gelators and proteins. Biomacromolecules 2013, 14, 4368-4376.
56. Sargent, J.F., Jr. Nanotechnology: A policy primer. Available online: http://digitalcommons.ilr.cornell.edu/cgi/viewcontent.cgi?article=1911&context=key_workplace (accessed on 28 September 2014).
57. Bohorquez, M.; Koch, C.; Trygstad, T.; Pandit, N. A Study of the Temperature-Dependent Micellization of Pluronic F127. J. Colloid Interface Sci. 1999, 216, 34-40.
58. Nie, S.; Hsiao, W.L.; Pan, W.; Yang, Z. Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: In vitro drug release, cell cytotoxicity, and uptake studies. Int. J. Nanomed. 2011, 6, 151-166.
59. Liaw, J.; Lin, Y. Evaluation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) gels as a release vehicle for percutaneous fentanyl. J. Control. Release 2000, 68, 273-282.
60. Barichello, J.M.; Morishita, M.; Takayama, K.; Nagai, T. Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats. Int. J. Pharm. 1999, 184, 189-198.
61. Escobar-Chavez, J.J.; Lopez-Cervantes, M.; Naik, A.; Kalia, Y.N.; Quintanar-Guerrero, D.; Ganem-Quintanar, A. Applications of thermo-reversible Pluronic F-127 gels in pharmaceutical formulations. J. Pharm. Pharm. Sci. 2006, 9, 339-358.
62. Wesenberg-Ward, K.E.; Tyler, B.J.; Sears, J.T. Adhesion and biofilm formation of Candida albicans on native and Pluronic-treated polystyrene. Biofilms 2005, 2, 63-71.
63. Veyries, M.L.; Faurisson, F.; Joly-Guillou, M.L.; Rouveix, B. Control of staphylococcal adhesion to polymethylmethacrylate and enhancement of susceptibility to antibiotics by poloxamer 407. Antimicrob. Agents Chemother. 2000, 44, 1093-1096.
64. Leszczynska, K.; Namiot, A.; Cruz, K.; Byfield, F.J.; Won, E.; Mendez, G.; Sokolowski, W.; Savage, P.B.; Bucki, R.; Janmey, P.A. Potential of ceragenin CSA-13 and its mixture with Pluronic F-127 as treatment of topical bacterial infections. J. Appl. Microbiol. 2011, 110, 229-238.
65. Kant, V.; Gopal, A.; Kumar, D.; Gopalkrishnan, A.; Pathak, N.N.; Kurade, N.P.; Tandan, S.K.; Kumar, D. Topical Pluronic F-127 gel application enhances cutaneous wound healing in rats. Acta Histochem. 2014, 116, 5-13.
66. Norris, P.; Noble, M.; Francolini, I.; Vinogradov, A.M.; Stewart, P.S.; Ratner, B.D.; Costerton, J.W.; Stoodley, P. Ultrasonically controlled release of ciprofloxacin from self-assembled coatings on poly(2-hydroxyethyl methacrylate) hydrogels for Pseudomonas aeruginosa biofilm prevention. Antimicrob. Agents Chemother. 2005, 49, 4272-4279.
67. Kruszewski, K.M.; Nistico, L.; Longwell, M.J.; Hynes, M.J.; Maurer, J.A.; Hall-Stoodley, L.; Gawalt, E.S. Reducing Staphylococcus aureus biofilm formation on stainless steel 316L using functionalized self-assembled monolayers. Mater. Sci. Eng. C Mater. Biol. Appl. 2013, 33, 2059-2069.
68. Hou, S.; Burton, E.A.; Simon, K.A.; Blodgett, D.; Luk, Y.Y.; Ren, D. Inhibition of Escherichia coli biofilm formation by self-assembled monolayers of functional alkanethiols on gold. Appl. Environ. Microbiol. 2007, 73, 4300-4307.
69. Wang, Q.; Uzunoglu, E.; Wu, Y.; Libera, M. Self-assembled poly(ethylene glycol)-co-acrylic acid microgels to inhibit bacterial colonization of synthetic surfaces. ACS Appl. Mater. Interfaces 2012, 4, 2498-2506.
70. Zhang, S.; Marini, D.M.; Hwang, W.; Santoso, S. Design of nanostructured biological materials through self-assembly of peptides and proteins. Curr. Opin. Chem. Biol. 2002, 6, 865-871.
71. Zhang, S.; Holmes, T.; Lockshin, C.; Rich, A. Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc. Natl. Acad. Sci. USA 1993, 90, 3334-3338.
72. Aggeli, A.; Nyrkova, I.A.; Bell, M.; Harding, R.; Carrick, L.; McLeish, T.C.; Semenov, A.N.; Boden, N. Hierarchical self-assembly of chiral rod-like molecules as a model for peptide beta-sheet tapes, ribbons, fibrils, and fibers. Proc. Natl. Acad. Sci. USA 2001, 98, 11857-11862.
73. Fields, G.B.; Tirrell, M.V. Self-Assembling Amphiphiles for Construction of Peptide Secondary Structures. Patent, US 08/702,254 and WO 1998007752 A1, 2000.
74. Ghadiri, M.R.; Granja, J.R.; Milligan, R.A.; McRee, D.E.; Khazanovich, N. Self-assembling organic nanotubes based on a cyclic peptide architecture. Nature 1993, 366, 324-327.
75. Rajagopal, K.; Schneider, J.P. Self-assembling peptides and proteins for nanotechnological applications. Curr. Opin. Struct. Biol. 2004, 14, 480-486.
76. Ulijn, R.V.; Smith, A.M. Designing peptide based nanomaterials. Chem. Soc. Rev. 2008, 37, 664-675.
77. Caplan, M.R.; Schwartzfarb, E.M.; Zhang, S.; Kamm, R.D.; Lauffenburger, D.A. Control of self-assembling oligopeptide matrix formation through systematic variation of amino acid sequence. Biomaterials 2002, 23, 219-227.
78. Hong, Y.; Pritzker, M.D.; Legge, R.L.; Chen, P. Effect of NaCl and peptide concentration on the self-assembly of an ionic-complementary peptide EAK16-II. Colloids Surf. B Biointerfaces 2005, 46, 152-161.
79. Joshi, N.S.; Whitaker, L.R.; Francis, M.B. A three-component Mannich-type reaction for selective tyrosine bioconjugation. J. Am. Chem. Soc. 2004, 126, 15942-15943.
80. Yang, Z.; Liang, G.; Wang, L.; Xu, B. Using a kinase/phosphatase switch to regulate a supramolecular hydrogel and forming the supramolecular hydrogel in vivo. J. Am. Chem. Soc. 2006, 128, 3038-3043.
81. Mahalka, A.K.; Kinnunen, P.K. Binding of amphipathic alpha-helical antimicrobial peptides to lipid membranes: Lessons from temporins B and L. Biochim. Biophys. Acta 2009, 1788, 1600-1609.
82. Paramonov, S.E.; Jun, H.W.; Hartgerink, J.D. Self-assembly of peptide-amphiphile nanofibers: The roles of hydrogen bonding and amphiphilic packing. J. Am. Chem. Soc. 2006, 128, 7291-7298.
83. Silva, G.A.; Czeisler, C.; Niece, K.L.; Beniash, E.; Harrington, D.A.; Kessler, J.A.; Stupp, S.I. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 2004, 303, 1352-1355.
84. Gazit, E. Self-assembled peptide nanostructures: The design of molecular building blocks and their technological utilization. Chem. Soc. Rev. 2007, 36, 1263-1269.
85. Martinez, C.R.; Iverson, B.I. Rethinking the term “pi-stacking”. Chem. Sci. 2012, 3, 2191-2201.
86. Burley, S.K.; Petsko, G.A. Aromatic-aromatic interaction: A mechanism of protein structure stabilization. Science 1985, 229, 23-28.
87. Reches, M.; Gazit, E. Casting metal nanowires within discrete self-assembled peptide nanotubes. Science 2003, 300, 625-627.
88. Yang, Z.; Gu, H.; Zhang, Y.; Wang, L.; Xu, B. Small molecule hydrogels based on a class of antiinflammatory agents. Chem. Commun. 2004, 2, 208-209.
89. Yang, Z.; Liang, G.; Ma, M.; Gao, Y.; Xu, B. Conjugates of naphthalene and dipeptides confer molecular hydrogelators with high efficiency of hydrogelation and superhelical nanofibers. J. Mater. Chem. 2007, 17, 850-854.
90. Kyle, S.; Aggeli, A.; Ingham, E.; McPherson, M.J. Production of self-assembling biomaterials for tissue engineering. Trends Biotechnol. 2009, 27, 423-433.
91. Avrahami, D.; Shai, Y. A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. J. Biol. Chem. 2004, 279, 12277-12285.
92. Peschel, A.; Sahl, H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 2006, 4, 529-536.
93. Yeaman, M.R.; Yount, N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003, 55, 27-55.
94. Jenssen, H.; Hamill, P.; Hancock, R.E. Peptide antimicrobial agents. Clin. Microbiol. Rev. 2006, 19, 491-511.
95. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389-395.
96. Matsuzaki, K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1999, 1462, 1-10.
97. Park, C.B.; Kim, H.S.; Kim, S.C. Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 1998, 244, 253-257.
98. Patrzykat, A.; Friedrich, C.L.; Zhang, L.; Mendoza, V.; Hancock, R.E. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother. 2002, 46, 605-614.
99. Hilpert, K.; McLeod, B.; Yu, J.; Elliott, M.R.; Rautenbach, M.; Ruden, S.; Burck, J.; Muhle-Goll, C.; Ulrich, A.S.; Keller, S. et al Short cationic antimicrobial peptides interact with ATP. Antimicrob. Agents Chemother. 2010, 54, 4480-4483.
100. Hancock, R.E.; Scott, M.G. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. USA 2000, 97, 8856-8861.
101. Finlay, B.B.; Hancock, R.E. Can innate immunity be enhanced to treat microbial infections? Nat. Rev. Microbiol. 2004, 2, 497-504.
102. Harris, F.; Dennison, S.R.; Phoenix, D.A. Anionic antimicrobial peptides from eukaryotic organisms. Curr. Protein Pept. Sci. 2009, 10, 585-606.
103. Grubor, B.; Meyerholz, D.K.; Ackermann, M.R. Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet. Pathol. 2006, 43, 595-612.
104. Brogden, K.A.; Ackermann, M.; McCray, P.B., Jr; Tack, B.F. Antimicrobial peptides in animals and their role in host defences. Int. J. Antimicrob. Agents 2003, 22, 465-478.
105. Schmidtchen, A.; Frick, I.M.; Andersson, E.; Tapper, H.; Bjorck, L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 2002, 46, 157-168.
106. Strom, M.B.; Haug, B.E.; Skar, M.L.; Stensen, W.; Stiberg, T.; Svendsen, J.S. The pharmacophore of short cationic antibacterial peptides. J. Med. Chem. 2003, 46, 1567-1570.
107. Bisht, G.S.; Rawat, D.S.; Kumar, A.; Kumar, R.; Pasha, S. Antimicrobial activity of rationally designed amino terminal modified peptides. Bioorg. Med. Chem. Lett. 2007, 17, 4343-4346.
108. Makovitzki, A.; Avrahami, D.; Shai, Y. Ultrashort antibacterial and antifungal lipopeptides. Proc. Natl. Acad. Sci. USA 2006, 103, 15997-16002.
109. Chen, Y.; Vasil, A.I.; Rehaume, L.; Mant, C.T.; Burns, J.L.; Vasil, M.L.; Hancock, R.E.; Hodges, R.S. Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides. Chem. Biol. Drug Des. 2006, 67, 162-173.
110. Straus, S.K.; Hancock, R.E. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta 2006, 1758, 1215-1223.
111. Zavascki, A.P.; Goldani, L.Z.; Li, J.; Nation, R.L. Polymyxin B for the treatment of multidrug-resistant pathogens: A critical review. J. Antimicrob. Chemother. 2007, 60, 1206-1215.
112. Levine, D.P.; Lamp, K.C. Daptomycin in the treatment of patients with infective endocarditis: Experience from a registry. Am. J. Med. 2007, 120, S28-S33.
113. Li, J.; Nation, R.L.; Turnidge, J.D.; Milne, R.W.; Coulthard, K.; Rayner, C.R.; Paterson, D.L. Colistin: The re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 2006, 6, 589-601.
114. Di Luca, M.; Maccari, G.; Nifosi, R. Treatment of microbial biofilms in the post-antibiotic era: Prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools. Pathog. Dis. 2014, 70, 257-270.
115. Park, S.C.; Park, Y.; Hahm, K.S. The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int. J. Mol. Sci. 2011, 12, 5971-5992.
116. Cirioni, O.; Silvestri, C.; Ghiselli, R.; Orlando, F.; Riva, A.; Mocchegiani, F.; Chiodi, L.; Castelletti, S.; Gabrielli, E.; Saba, V. et al Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. J. Antimicrob. Chemother. 2008, 62, 1332-1338.
117. Milne, K.E.; Gould, I.M. Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients. Antimicrob. Agents Chemother. 2012, 56, 4071-4077.
118. Medina-Polo, J.; Jimenez-Alcaide, E.; Garcia-Gonzalez, L.; Guerrero-Ramos, F.; Perez-Cadavid, S.; Arrebola-Pajares, A.; Sopena-Sutil, R.; Benitez-Salas, R.; Diaz-Gonzalez, R.; Tejido-Sanchez, A. Healthcare-associated infections in a department of urology: Incidence and patterns of antibiotic resistance. Scand. J. Urol. 2014, 48, 203-209.
119. Hancock, R.E.; Sahl, H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006, 24, 1551-1557.
120. Haug, B.E.; Stensen, W.; Stiberg, T.; Svendsen, J.S. Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides. J. Med. Chem. 2004, 47, 4159-4162.
121. Pasupuleti, M.; Schmidtchen, A.; Chalupka, A.; Ringstad, L.; Malmsten, M. End-tagging of ultrashort antimicrobial peptides by W/F stretches to facilitate bacterial killing. PLoS One 2009, 4, e5285.
122. Rotem, S.; Radzishevsky, I.S.; Bourdetsky, D.; Navon-Venezia, S.; Carmeli, Y.; Mor, A. Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J. 2008, 22, 2652-2661.
123. Rotem, S.; Raz, N.; Kashi, Y.; Mor, A. Bacterial capture by peptide-mimetic oligoacyllysine surfaces. Appl. Environ. Microbiol. 2010, 76, 3301-3307.
124. Livne, L.; Epand, R.F.; Papahadjopoulos-Sternberg, B.; Epand, R.M.; Mor, A. OAK-based cochleates as a novel approach to overcome multidrug resistance in bacteria. FASEB J. 2010, 24, 5092-5101.
125. Sarig, H.; Ohana, D.; Epand, R.F.; Mor, A.; Epand, R.M. Functional studies of cochleate assemblies of an oligo-acyl-lysyl with lipid mixtures for combating bacterial multidrug resistance. FASEB J. 2011, 25, 3336-3343.
126. Jain, A.; Jain, A.; Gulbake, A.; Shilpi, S.; Hurkat, P.; Jain, S.K. Peptide and protein delivery using new drug delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 2013, 30, 293-329.
127. Karin, N.; Binah, O.; Grabie, N.; Mitchell, D.J.; Felzen, B.; Solomon, M.D.; Conlon, P.; Gaur, A.; Ling, N.; Steinman, L. Short peptide-based tolerogens without self-antigenic or pathogenic activity reverse autoimmune disease. J. Immunol. 1998, 160, 5188-5194.
128. Mack, D.; Rohde, H.; Harris, L.G.; Davies, A.P.; Horstkotte, M.A.; Knobloch, J.K. Biofilm formation in medical device-related infection. Int. J. Artif. Organs 2006, 29, 343-359.
129. Rughani, R.V.; Salick, D.A.; Lamm, M.S.; Yucel, T.; Pochan, D.J.; Schneider, J.P. Folding, self-assembly, and bulk material properties of a de novo designed three-stranded beta-sheet hydrogel. Biomacromolecules 2009, 10, 1295-1304.
130. Haines, L.A.; Rajagopal, K.; Ozbas, B.; Salick, D.A.; Pochan, D.J.; Schneider, J.P. Light-activated hydrogel formation via the triggered folding and self-assembly of a designed peptide. J. Am. Chem. Soc. 2005, 127, 17025-17029.
131. Hughes, M.; Debnath, S.; Knapp, C.W.; Ulijn, R.V. Antimicrobial properties of enzymatically triggered self-assembling aromatic peptide amphiphiles. Biomater. Sci. 2013, 1, 1138-1142.
132. Schneider, J.P.; Pochan, D.J.; Ozbas, B.; Rajagopal, K.; Pakstis, L.; Kretsinger, J. Responsive hydrogels from the intramolecular folding and self-assembly of a designed peptide. J. Am. Chem. Soc. 2002, 124, 15030-15037.
133. Kretsinger, J.K.; Haines, L.A.; Ozbas, B.; Pochan, D.J.; Schneider, J.P. Cytocompatibility of selfassembled beta-hairpin peptide hydrogel surfaces. Biomaterials 2005, 26, 5177-5186.
134. Haines-Butterick, L.; Rajagopal, K.; Branco, M.; Salick, D.; Rughani, R.; Pilarz, M.; Lamm, M.S.; Pochan, D.J.; Schneider, J.P. Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells. Proc. Natl. Acad. Sci. USA 2007, 104, 7791-7796.
135. Veiga, A.S.; Sinthuvanich, C.; Gaspar, D.; Franquelim, H.G.; Castanho, M.A.; Schneider, J.P. Arginine-rich self-assembling peptides as potent antibacterial gels. Biomaterials 2012, 33, 8907-8916.
136. Yokoi, H.; Kinoshita, T.; Zhang, S. Dynamic reassembly of peptide RADA16 nanofiber scaffold. Proc. Natl. Acad. Sci. USA 2005, 102, 8414-8419.
137. Schneider, A.; Garlick, J.A.; Egles, C. Self-assembling peptide nanofiber scaffolds accelerate wound healing. PLoS One 2008, 3, e1410.
138. Debnath, S.; Shome, A.; Das, D.; Das, P.K. Hydrogelation through self-assembly of fmoc-peptide functionalized cationic amphiphiles: Potent antibacterial agent. J. Phys. Chem. B 2010, 114, 4407-4415.
139. Williams, G.J.; Stickler, D.J. Some observations on the migration of Proteus mirabilis and other urinary tract pathogens over foley catheters. Infect. Control Hosp. Epidemiol. 2008, 29, 443-445.
140. McCoy, C.P.; Craig, R.A.; McGlinchey, S.M.; Carson, L.; Jones, D.S.; Gorman, S.P. Surface localisation of photosensitisers on intraocular lens biomaterials for prevention of infectious endophthalmitis and retinal protection. Biomaterials 2012, 33, 7952-7958.
141. Pochan, D.J.; Schneider, J.P.; Kretsinger, J.; Ozbas, B.; Rajagopal, K.; Haines, L. Thermally reversible hydrogels via intramolecular folding and consequent self-assembly of a de novo designed peptide. J. Am. Chem. Soc. 2003, 125, 11802-11803.
142. Tang, C.; Ulijn, R.V.; Saiani, A. Effect of glycine substitution on Fmoc-diphenylalanine self-assembly and gelation properties. Langmuir 2011, 27, 14438-14449.
143. Tang, C.; Ulijn, R.V.; Saiani, A. Self-assembly and gelation properties of glycine/leucine Fmocdipeptides. Eur. Phys. J. E. 2013, 36, 111.
144. Wu, L.Q.; Payne, G.F. Biofabrication: Using biological materials and biocatalysts to construct nanostructured assemblies. Trends Biotechnol. 2004, 22, 593-599.
145. Hughes, M.; Frederix, P.W.J.M.; Raeburn, J.; Birchall, L.S.; Sadownik, J.; Coomer, F.C.; Lin, I.H.; Cussen, E.J.; Hunt, N.T.; Tuttle, T. et al Sequence/structure relationships in aromatic dipeptide hydrogels formed under thermodynamic control by enzyme-assisted self-assembly. Soft Matter 2012, 8, 5595-5602.
146. Hughes, M.; Birchall, L.S.; Zuberi, K.; Aitken, L.A.; Debnath, S.; Javida, N.; Ulijn, R.V. Differential supramolecular organization of Fmoc-dipeptides with hydrophilic terminal amino acid residues by biocatalytic self-assembly. Soft Matter 2012, 8, 11565-11574.
147. Toledano, S.; Williams, R.J.; Jayawarna, V.; Ulijn, R.V. Enzyme-triggered self-assembly of peptide hydrogels via reversed hydrolysis. J. Am. Chem. Soc. 2006, 128, 1070-1071.
148. Wang, H.; Yang, C.; Tan, M.; Wang, L.; Konga, D.; Yang, Z. A structure-gelation ability study in a short peptide-based ‘Super Hydrogelator’ system. Soft Matter 2011, 7, 1070-1071.
149. Derman, A.I.; Beckwith, J. Escherichia coli alkaline phosphatase localized to the cytoplasm slowly acquires enzymatic activity in cells whose growth has been suspended: A caution for gene fusion studies. J. Bacteriol. 1995, 177, 3764-3770.
150. Yang, K.; Metcalf, W.W. A new activity for an old enzyme: Escherichia coli bacterial alkaline phosphatase is a phosphite-dependent hydrogenase. Proc. Natl. Acad. Sci. USA 2004, 101, 7919-7924.
151. Yang, Z.; Ho, P.K.; Liang, G.; Chow, K.H.; Wang, Q.; Cao Y.; Guo, Z.; Xu, B. Using β-lactamase to trigger supramolecular hydrogelation. J. Am. Chem. Soc. 2007, 129, 266-267.
152. Valery, C.; Paternostre, M.; Robert, B.; Gulik-Krzywicki, T.; Narayanan, T.; Dedieu, J.C.; Keller, G.; Torres, M.L.; Cherif-Cheikh, R.; Calvo, P. et al Biomimetic organization: Octapeptide self-assembly into nanotubes of viral capsid-like dimension. Proc. Natl. Acad. Sci. USA 2003, 100, 10258-10262.
153. Marchesan, S.; Qu, Y.; Waddington, L.J.; Easton, C.D.; Glattauer, V.; Lithgow, T.J.; McLean, K.M.; Forsythe, J.S.; Hartley, P.G. Self-assembly of ciprofloxacin and a tripeptide into an antimicrobial nanostructured hydrogel. Biomaterials 2013, 34, 3678-3687.
154. Paladini, F.; Meikle, S.T.; Cooper, I.R.; Lacey, J.; Perugini, V.; Santin, M. Silver-doped self-assembling di-phenylalanine hydrogels as wound dressing biomaterials. J. Mater. Sci. Mater. Med. 2013, 24, 2461-2472.
155. Wang, Y.; Cao, L.; Guan, S.; Shi, G.; Luo, Q.; Miao, L.; Thistlethwaite, I.; Huang, Z.; Xu, J.; Liu, J. Silver mineralization on self-assembled peptide nanofibers for long term antimicrobial effect. J. Mater. Chem. 2012, 22, 2575-2581.
156. Liu, L.; Xu, K.; Wang, H.; Tan, P.K.; Fan, W.; Venkatraman, S.S.; Li, L.; Yang, Y.Y. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat. Nanotechnol. 2009, 4, 457-463.
157. Laverty, G.; McCloskey, A.; Gilmore, B.F.; Jones, D.S.; Zhou, J.; Xu, B. Ultrashort cationic naphthalene-derived self-Assembled peptides as antimicrobial nanomaterials. Biomacromolecules 2014, 15, 3429-3439.